Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Viking Therapeutics Stock Pops But Struggles to Hold Gains

VKTX stock shot higher after announcing a phase 3 trial for its GLP-1 drug candidate; but investors are concerned about a lack of support in Washington

Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited

Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited

Qualcomm just earned its first Buy rating in months, with TD Cowen targeting 15% upside ahead of earnings in two weeks.

Meta Stock Holds Upside Potential as Analysts Cut Price Targets

Meta Stock Holds Upside Potential as Analysts Cut Price Targets

Many recent analyst price target updates lowered expectations on Meta Platforms by north of 10%. However, upside is still in play for this advertising king.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Gold Rally Continues: These 3 Mining Stocks Are Likely to Benefit

Gold mining stocks typically lag the price of physical gold, which means 2025 may be a big year for these three gold miners

Tesla Stock Eyes Breakout With Earnings on Deck

Tesla is down nearly 50% from its highs, but analysts still see 40% upside ahead of earnings. A double bottom and rising RSI signal a possible reversal.

3 High-Value Companies With Triple-Digit Upside Potential

Impinj, Northern Technologies, and Seadrill have faced share price drops due to various causes, but investors also may have reason to be bullish on each.

Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?

Johnson & Johnson had more good than bad; investors should look at the entire report in context before deciding if JNJ stock is a good fit for their portfolios

inkl

Read news from The Economist, FT, and more,
with one subscription

The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?

The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?

Amid market turbulence and policy shifts, do two of the S&P 500’s steepest decliners, DECK and CRL, offer deep value or signal deeper trouble ahead?

Disney: How the Fubo Sports Deal Became a Game Changer

Disney: How the Fubo Sports Deal Became a Game Changer

Disney's deal with FuboTV is a game changer for both companies as they seek to defend their moats against Netflix, Amazon, YouTube TV and Sling TV in a win-win.

Lemonade: Leveraging AI to Underwrite a Path to Profitability

Lemonade is a disrupter in the insurance industry with its AI-powered platform that can underwrite a personalized policy in less than 90 seconds.

2 Penny Stocks With $10 Potential

2 Penny Stocks With $10 Potential

Penny stocks are a dime a dozen, but KORE Group Holdings and Banzai International stand out as high-probability winners that could reach $10 quickly.

Why Uber’s Stock Could Soar on AV Growth and Tariff Resilience

Why Uber’s Stock Could Soar on AV Growth and Tariff Resilience

Uber is scaling profits, expanding margins, and entering AVs with a smart, asset-light model. Here’s why the stock could ride higher in 2025.

Beware of BigBear.ai: Insiders Are Selling—Should You?

Beware of BigBear.ai: Insiders Are Selling—Should You?

BigBear.ai's recent disappointing performance has significantly impacted its stock valuation, drawing intense scrutiny from the investment community.

CrowdStrike Stock is a Buy as Cyberthreat Environment Expands

CrowdStrike Stock is a Buy as Cyberthreat Environment Expands

CRWD stock is up 7% in the last month and could retake its all-time high as the company's Falcon platform continues to see high adoption and retention

Get all your
news in one place.

100’s of premium titles.
One news app.

Congress! Who Traded What During the Tariff-Induced Meltdown

Members of Congress were active traders during the tariff-induced market meltdown, and the activity wasn't isolated to a single party or house.

2 Under-the-Radar Consumer Staples Stocks With Big Dividends

Edgewell and Kenvue are under-the-radar consumer staples stocks poised to gain as the U.S. dollar declines. Learn why they may boost your income portfolio.

NATO Deal Sparks 4% Jump in Palantir Stock—What’s Next?

Palantir stock rises 4% after a NATO AI deal and new U.S. Army contract ease funding fears. Here’s why analysts are turning bullish on PLTR.

3 Safe Stocks to Keep During Tariff Uncertainty

During one of the most volatile weeks in the history of the S&P 500, three stocks stand out for their stability in price action driven by fundamentals.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 ETFs Thriving in April’s Market Chaos—Are You Missing Out?

These ETFs beat the S&P 500 in April 2025’s turbulent market. Learn how TOLZ, VIXY, and KURE can help stabilize your investment strategy.

Financial Sector: Pullback Opportunity or Warning Sign?

While the overall market has seen a steep selloff, financials (XLF ETF) have outperformed, declining just 3.4% YTD versus nearly 9% for the S&P 500.

Buffett Loves Occidental Petroleum—Should You? 4 Pros, 3 Cons

Buffett hasn’t sold a single OXY share in 2025. Discover if now is the right time to invest in Occidental Petroleum amid oil price drops and debt concerns.

Traders Started Betting on PayPal's Rally Again

PayPal stock has fallen due to tariff fears, though this recent price action may prove to be a temporary one filled with upside potential.

Is BlackRock Signaling a Market Rally Despite New Tariffs?

BlackRock, the world's largest asset manager, just released its quarterly earnings report to show investors a potentially bullish view on the economy.

Microsoft: A Blend of Growth and Value Amid Tariff Concerns

Microsoft is a blue-chip stock that plays the role of a growth stock and value stock for investors who have a long-term outlook

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.

People

Marjorie Taylor Greene

Dara Khosrowshahi

Josh Gottheimer

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

261,375 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play